Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.49 USD 0.46% Market Closed
Market Cap: 836m USD
Have any thoughts about
Cytek Biosciences Inc?
Write Note

Cytek Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytek Biosciences Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cytek Biosciences Inc
NASDAQ:CTKB
Cash from Operating Activities
$5.3m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Operating Activities
$9.1B
CAGR 3-Years
-4%
CAGR 5-Years
13%
CAGR 10-Years
14%
Danaher Corp
NYSE:DHR
Cash from Operating Activities
$6.3B
CAGR 3-Years
-9%
CAGR 5-Years
9%
CAGR 10-Years
6%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Operating Activities
$983.6m
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Cash from Operating Activities
$1.8B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
9%
IQVIA Holdings Inc
NYSE:IQV
Cash from Operating Activities
$2.6B
CAGR 3-Years
-5%
CAGR 5-Years
16%
CAGR 10-Years
21%
No Stocks Found

Cytek Biosciences Inc
Glance View

Market Cap
853.5m USD
Industry
Life Sciences Tools & Services

Cytek Biosciences, Inc. is a life sciences technology company engages in the provision of cell analysis tools by leveraging novel technical approaches. The company is headquartered in Fremont, California and currently employs 496 full-time employees. The company went IPO on 2021-07-23. The firm offers cell analysis tools by leveraging technical approaches. Its instruments, the Aurora and Northern Lights systems, are the spectrum flow cytometers able to deliver cell analysis by utilizing the spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells Full Spectrum Profiling (FSP). The Company’s FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize a method of light detection and distribution. Its FSP platform includes instruments, reagents, software and services to provide an integrated suite of solutions for its customers. The firm has sold and deployed over 1,000 instruments, primarily comprised of its Aurora and Northern Lights systems to customers around the world, including the pharmaceutical companies, over 150 biopharma companies, academic research centers, and clinical research organizations (CROs).

CTKB Intrinsic Value
5.99 USD
Overvaluation 8%
Intrinsic Value
Price

See Also

What is Cytek Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
5.3m USD

Based on the financial report for Dec 31, 2023, Cytek Biosciences Inc's Cash from Operating Activities amounts to 5.3m USD.

What is Cytek Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-30%

The average annual Cash from Operating Activities growth rates for Cytek Biosciences Inc have been -30% over the past three years .

Back to Top